Indeed, increased levels of the proresolving mediator LXA4 and FPR2/ALX are detected in human pathologies, including RA [31] and acute post-streptococcal glomerulonephritis [32], suggesting that protective mediators and their receptors are may be operative within inflammatory settings to aid resolution. This evidence concerns the gene FPR2 and rheumatoid arthritis.